Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • What oncologists really want from booth strategy

    August 19, 2025 | Congress, Inizio, oncology 

    - PMLiVE

    Simon Davenport, Global Head of Environments, Emota, an Inizio Engage company 

    At this year’s ASCO® congress, the spotlight wasn’t just on science – it was on how the industry engages. Supporting over 30 clients and delivering 185 projects, Inizio witnessed the shift toward smarter, more sustainable congress environments.

    Key takeaways included:

    • Oncologists want interactive learning: Engagement is moving beyond slides, with responsive booths, interactive LED walls, and digital-first experiences extending conversations well past the industry’s six-minute average.

    • Smart spaces are here to stay: With heat mapping, AI-powered personalization, and real-time content optimization, booths are evolving into dynamic, intelligent environments that adapt to audience needs.

    • Sustainability as strategy: Inizio’s circularity-first booth design delivered a 70% CO₂e reduction, 70.7% recyclability, and major cost savings – results that earned industry-leading awards and set a benchmark for measurable impact.

    In a crowded oncology market, strategy-led storytelling, analytics-driven design, and sustainability-centered innovation are becoming essential to cut through the noise. The future of congress engagement will be intentional, data-informed, and deeply aligned with healthcare professionals’ learning preferences.

    Read Simon’s full article here, or explore more in Inizio’s on-demand webinar Beyond the booth: Big ideas, smart spaces & strategic insights from ASCO® 2025.

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    12 Challenges Big Pharma Faces in China

    Published in eyeforpharma 16 November by Rachel Howard

    Using mobile “diary” research to capture patient-generated insights in COPD

    Our latest case study demonstrates how a mobile app methodology was used to deliver key insights into issues faced by COPD patients

    Biosimilars in 2018: EU doctors’ perceptions of RA drug market

    Published in pharmaphorum October 2015 by Laurent Chanroux

    Webinar: Understanding the Patient Journey in China 2015

    Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.

    Understanding Patient Willingness to Pay

    Published in eyeforpharma 12 October by Rachel Howard

    Infographic: Spondyloarthritis

    Overview of spondyloarthritis patient profiles and treatment pathways.

    Webinar: Demand assessment – Reflecting real world choices

    How study design which reflects doctors’ real world choices can optimise results.

    Evaluating the potential of a pre-launch prodct in a real-life setting

    Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.

    Competition from within

    Published in eyeforpharma July 29 by Rachel Howard

    Infographic: RA Perceptions

    HCPs predict the future of the biologics market